June 12 (Reuters) – GlaxoSmithKline Plc said the
president of its vaccines business, Luc Debruyne, would leave
the company at the end of the year.
Roger Connor, currently president of its global
manufacturing and supply division, would replace Debruyne on
(Reporting by Justin George Varghese in Bengaluru; Editing by